张锋院士团队长期深耕基因编辑领域，成果丰硕，在 CRISPR-Cas 技术的发展和应用拓展上贡献卓越。在前期研究中，团队率先将 CRISPR-Cas9 ...

Scientists are exploring gene editing as a way to correct trisomy at the cellular level. Using CRISPR-Cas9, researchers ...

撰文丨王聪编辑 | 王多鱼排版 | 水成文CRISPR-Cas 系统是细菌和古菌的适应性免疫系统，能够抵御病毒和可移动遗传元件的入侵。尽管 CRISPR-Cas9 和 CRISPR-Cas12 系统的 DNA 靶向机制已经被广泛研究，但 RNA ...

ERS Genomics ('ERS'), which was established to provide broad access to the foundational CRISPR/Cas9 intellectual property ...

No doubt 2025 will usher in many more advances in CRISPR therapies, thanks to the FDA’s new Platform Technology Designation ...

Although plant cell-based bioproduction has advanced considerably during the past several years, certain elements remain largely unexplored.

The future of medicine with CRISPR and CAR-T therapy, exploring ethical, societal, and accessibility challenges in healthcare ...

CRISPR technology, driven by Cas9, redefines gene editing, facilitating targeted DNA modifications that advance genetic ...

Gene editing techniques may eventually allow trisomy to be treated at the cellular level, according to an in vitro ...

In December 2023, through the development efforts of CRISPR Therapeutics and Vertex Pharmaceuticals, their decades-long ...

The evolution of cell and gene therapy is reshaping drug discovery, providing new hope for rare diseases and cancer through ...

2025年2月18日，国际知名期刊《PNAS ...